Class II

Drug Recall: Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43

Glenmark Pharmaceuticals Inc., USA · September 24, 2024

Reason for Recall

Defective Delivery System: The dip tube is clogged causing the spray not to work.

Product Description

Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

45,504 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0006-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.